Trial Outcomes & Findings for Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain? (NCT NCT01070771)

NCT ID: NCT01070771

Last Updated: 2019-05-22

Results Overview

This outcome measure was assessing agreement in the management plan (MP) derived from angiographic assessment alone compared to a MP derived from angiographic assessment plus the use of FFR data acquired at the time of angiography. The study assessed the proportion of cases in which the angiogram directed MP changed after FFR data were disclosed.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

203 participants

Primary outcome timeframe

Up until hospital discharge. Most cases were day cases but no specific data relating to length of stay collected.

Results posted on

2019-05-22

Participant Flow

Participant milestones

Participant milestones
Measure
Radi Pressure Wire
Assessment of physiological significance of coronary artery narrowings by measurement of blood flow limitation across lesion.
Overall Study
STARTED
203
Overall Study
COMPLETED
200
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Radi Pressure Wire
Assessment of physiological significance of coronary artery narrowings by measurement of blood flow limitation across lesion.
Overall Study
Adverse Event
2
Overall Study
Protocol Violation
1

Baseline Characteristics

Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Radi Pressure Wire
n=200 Participants
Age, Continuous
64 years
STANDARD_DEVIATION 10 • n=5 Participants
Sex: Female, Male
Female
51 Participants
n=5 Participants
Sex: Female, Male
Male
149 Participants
n=5 Participants
Region of Enrollment
United Kingdom
200 participants
n=5 Participants

PRIMARY outcome

Timeframe: Up until hospital discharge. Most cases were day cases but no specific data relating to length of stay collected.

This outcome measure was assessing agreement in the management plan (MP) derived from angiographic assessment alone compared to a MP derived from angiographic assessment plus the use of FFR data acquired at the time of angiography. The study assessed the proportion of cases in which the angiogram directed MP changed after FFR data were disclosed.

Outcome measures

Outcome measures
Measure
Radi Pressure Wire
n=200 Participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Agreement with management plan
147 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Change in management plan after FFR
53 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Recommended medical treatment alone
72 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Revascularisation was advised after FFR
9 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Optimal medical therapy recommended after FFR
89 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Recommended revascularisation after angiogram
25 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Recommendation of PCI after angio assessment
90 participants
Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG)
Of the 90 FFR detected no significant stenosis
24 participants

SECONDARY outcome

Timeframe: Up to hospital discharge. Most were day case procedures but no specific data relating to discharge was collected.

This compared the number of vessels in which there was a discrepant result in relation to angiographically and FFR defined significance. Angiographic significance was visually assessed by operators whereas the pressure wire provided objective data as to a narrowing's significance: an FFR reading of \<0.8 indicated a significant restriction in blood flow with a recommendation for revascularisation. The difference in indication for revascularisation of each major coronary artery was also judged according to angiogram alone compared with angiogram plus FFR dtaa.

Outcome measures

Outcome measures
Measure
Radi Pressure Wire
n=200 Participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
significant 3 vessel disease at angio:negative FFR
1 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
Number of vessels significantly changed after FFR
64 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
No significant CAD after angiography alone
81 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
Of the 81, significant FFR (<0.8)
18 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
No haemodynamically signifiacnt CAD after FFR
89 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
Of the 89, angio labelled as single vessel disease
24 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
of the 89, angio labelled as 2 vessel disease
1 participants
To Determine the Level of Agreement in Management Plans Regarding the Significance of Coronary Artery Narrowings When Comparing the MP Acquired by Standard Angiographic Assessment Alone and a MP Acquired Using Angiographic Assessment Plus FFR Data.
of the 89, angio labelled as 3 vessel disease
1 participants

Adverse Events

RADI Pressure Wire

Serious events: 3 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
RADI Pressure Wire
n=200 participants at risk
Cardiac disorders
Vessel occlusion
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
Cardiac disorders
Coronary artery dissection
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
Cardiac disorders
Ventricular fibrillation
0.50%
1/200 • Number of events 1
Only serious adverse events were collected
Vascular disorders
Deep vein thrombosis
0.50%
1/200 • Number of events 1
Only serious adverse events were collected

Other adverse events

Adverse event data not reported

Additional Information

Professor Nick Curzen

University Hospital Southampton NHS Foundation Trust

Phone: +44 023 80777222

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60